Kadefungin 6

Clotrimazole, the active ingredient in Kadefungin 6, is an imidazole antifungal presented as a vaginal formulation for vaginal use. It is indicated for the treatment of vaginal candidiasis, a common yeast infection, by targeting the fungal cells that cause itching, discharge, and irritation in adult women.

GNH USA supplies Kadefungin 6 as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide. The company ensures reliable global distribution and supports regulatory compliance for its partners.

Clotrimazole is an imidazole antifungal that acts on Candida species affecting the genital tract.

- Vaginal candidiasis: alleviates itching, discharge, and irritation by eradicating the yeast infection. - Prevention of recurrent vaginal candidiasis: reduces the frequency of future episodes when used as directed. - Treatment of mild to moderate Candida infection of the vagina: restores normal vaginal flora and relieves symptoms.

Clotrimazole may cause local adverse reactions, most of which are mild, transient, and confined to the vaginal area.

Common Side Effects: - Burning or stinging at the site of application, usually lasting a few minutes. - Vaginal itching or mild irritation, which typically resolves without treatment. - Light vaginal discharge that may be whitish or clear and transient.

Serious or Rare Side Effects: - Allergic reaction with rash, swelling, or hives that may require medical attention. - Severe skin reactions such as Stevens‑Johnson syndrome, characterized by blistering and detachment of skin. - Anaphylaxis, a rapid, life‑threatening allergic response requiring emergency care.

When using Kadefungin 6